Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
MJ Wieduwilt, L Metheny III, MJ Zhang… - Blood …, 2022 - ashpublications.org
The role of haploidentical hematopoietic cell transplantation (HCT) using posttransplant
cyclophosphamide (PTCy) for acute lymphoblastic leukemia (ALL) is being defined. We …
cyclophosphamide (PTCy) for acute lymphoblastic leukemia (ALL) is being defined. We …
Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy
M Shadman, J Gauthier, KA Hay, JM Voutsinas… - Blood …, 2019 - ashpublications.org
Allogeneic hematopoietic cell transplantation (allo-HCT) is offered to selected patients after
chimeric antigen receptor–modified T-cell (CAR-T) therapy. Lymphodepleting chemotherapy …
chimeric antigen receptor–modified T-cell (CAR-T) therapy. Lymphodepleting chemotherapy …
Younger matched unrelated donors confer decreased relapse risk compared to older sibling donors in older patients with B cell acute lymphoblastic leukemia …
MB Abid, N Estrada-Merly, MJ Zhang, K Chen… - … and Cellular Therapy, 2023 - Elsevier
Although allogeneic hematopoietic cell transplantation (alloHCT) offers cure for older
patients with acute lymphoblastic leukemia (ALL), disease relapse remains a major issue …
patients with acute lymphoblastic leukemia (ALL), disease relapse remains a major issue …
Review of genetic variation as a predictive biomarker for chronic graft-versus-host-disease after allogeneic stem cell transplantation
J Partanen, K Hyvärinen, H Bickeböller… - Frontiers in …, 2020 - frontiersin.org
Chronic graft-versus-host disease (cGvHD) is one of the major complications of allogeneic
stem cell transplantation (HSCT). cGvHD is an autoimmune-like disorder affecting multiple …
stem cell transplantation (HSCT). cGvHD is an autoimmune-like disorder affecting multiple …
Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state
SS Saadeh, MR Litzow - Expert Review of Hematology, 2018 - Taylor & Francis
Introduction: Allogeneic hematopoietic stem cell transplant (allo-HSCT) has an important
role in management of acute lymphoblastic leukemia (ALL). Proper patient selection is …
role in management of acute lymphoblastic leukemia (ALL). Proper patient selection is …
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
SO Ciurea, MCB Bittencourt, DR Milton, K Cao… - Blood …, 2018 - ashpublications.org
Donor availability for allogeneic transplantation remains an important factor in determining
outcomes of a successful transplant. We examined outcomes of 242 patients treated over 3 …
outcomes of a successful transplant. We examined outcomes of 242 patients treated over 3 …
[HTML][HTML] Long-term results of allogeneic stem cell transplantation in adult Ph-negative high-risk acute lymphoblastic leukemia
DW Beelen, R Arnold, M Stelljes, N Alakel… - … and Cellular Therapy, 2022 - Elsevier
Allogeneic hematopoietic stem cell transplantation (HCT) is standard treatment for adult high-
risk (HR) acute lymphoblastic leukemia (ALL) and contributed to the overall improved …
risk (HR) acute lymphoblastic leukemia (ALL) and contributed to the overall improved …
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia; current evidence, and improving outcomes going …
JT Leonard, B Hayes-Lattin - Current hematologic malignancy reports, 2018 - Springer
Abstract Purpose of Review Outcomes for older adults with acute lymphoblastic leukemia
(ALL) remain poor, and allogeneic hematopoietic stem cell transplant (HSCT) remains a …
(ALL) remain poor, and allogeneic hematopoietic stem cell transplant (HSCT) remains a …
[HTML][HTML] Predictive factors and outcomes after allogeneic stem cell transplantation for adults with acute lymphoblastic leukemia in Brazil
WF Silva, DN Cysne, MN Kerbauy, I Colturato… - … and Cellular Therapy, 2022 - Elsevier
Allogeneic stem cell transplantation (HSCT) remains a potentially curative approach for
acute lymphoblastic leukemia (ALL), especially for high-risk patients and those with …
acute lymphoblastic leukemia (ALL), especially for high-risk patients and those with …
Who should receive a transplant for acute lymphoblastic leukaemia?
R Dhawan, DI Marks - Current hematologic malignancy reports, 2017 - Springer
Allogeneic haematopoietic cell transplantation continues to be an important curative therapy
for acute lymphoblastic leukaemia (ALL). Traditionally accepted indications for allografting …
for acute lymphoblastic leukaemia (ALL). Traditionally accepted indications for allografting …